JPS623127B2 - - Google Patents

Info

Publication number
JPS623127B2
JPS623127B2 JP53022385A JP2238578A JPS623127B2 JP S623127 B2 JPS623127 B2 JP S623127B2 JP 53022385 A JP53022385 A JP 53022385A JP 2238578 A JP2238578 A JP 2238578A JP S623127 B2 JPS623127 B2 JP S623127B2
Authority
JP
Japan
Prior art keywords
stimulation
drug
therapeutic agent
threshold
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53022385A
Other languages
English (en)
Japanese (ja)
Other versions
JPS54117034A (en
Inventor
Tadashi Nakajima
Kyoji Rikimi
Yasuji Muneda
Kenichi Kashima
Akira Myamoto
Hirokazu Soejima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shoji Co Ltd
Original Assignee
Nippon Shoji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shoji Co Ltd filed Critical Nippon Shoji Co Ltd
Priority to JP2238578A priority Critical patent/JPS54117034A/ja
Priority to DE19792907778 priority patent/DE2907778A1/de
Priority to NL7901601A priority patent/NL7901601A/xx
Publication of JPS54117034A publication Critical patent/JPS54117034A/ja
Priority to US06/146,215 priority patent/US4263286A/en
Publication of JPS623127B2 publication Critical patent/JPS623127B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2238578A 1978-02-28 1978-02-28 Treating agent for consciousness and perception motion disorder Granted JPS54117034A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2238578A JPS54117034A (en) 1978-02-28 1978-02-28 Treating agent for consciousness and perception motion disorder
DE19792907778 DE2907778A1 (de) 1978-02-28 1979-02-28 Verwendung von phosphatidylverbindungen in arzneimitteln gegen wahrnehmungs-, bewusstseins- und bewegungsstoerungen
NL7901601A NL7901601A (nl) 1978-02-28 1979-02-28 Geneesmiddel voor bewustzijnsstoornissen en perceptie en bewegingsstoornissen.
US06/146,215 US4263286A (en) 1978-02-28 1980-05-05 Therapeutic agent for consciousness disorder and perception and movement disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2238578A JPS54117034A (en) 1978-02-28 1978-02-28 Treating agent for consciousness and perception motion disorder

Publications (2)

Publication Number Publication Date
JPS54117034A JPS54117034A (en) 1979-09-11
JPS623127B2 true JPS623127B2 (cg-RX-API-DMAC7.html) 1987-01-23

Family

ID=12081179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2238578A Granted JPS54117034A (en) 1978-02-28 1978-02-28 Treating agent for consciousness and perception motion disorder

Country Status (4)

Country Link
US (1) US4263286A (cg-RX-API-DMAC7.html)
JP (1) JPS54117034A (cg-RX-API-DMAC7.html)
DE (1) DE2907778A1 (cg-RX-API-DMAC7.html)
NL (1) NL7901601A (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5566512A (en) * 1978-11-15 1980-05-20 Massachusetts Inst Technology Method and composition for treating difficulties by administration of choline or choline dissociating compound
JPS55115824A (en) * 1979-02-28 1980-09-06 Nippon Shoji Kk Remedy for clouding of consciousness and sensomobile disorder
IT1123142B (it) * 1979-09-14 1986-04-30 Lpb Ist Farm Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
DE3228629A1 (de) * 1982-07-31 1984-02-02 Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
DE3346525C2 (de) * 1983-12-22 1987-03-19 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
US4921706A (en) * 1984-11-20 1990-05-01 Massachusetts Institute Of Technology Unilamellar lipid vesicles and method for their formation
US5011964A (en) * 1985-03-07 1991-04-30 Cornell Research Foundation, Inc. Novel diacylglycerophosphoric acid esters and use thereof as substrates in enzyme assays
IT1199972B (it) * 1985-05-08 1989-01-05 Lpb Ist Farm Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
US4923854A (en) * 1986-01-22 1990-05-08 The Liposome Company, Inc. Solubilization of hydrophobic materials using lysophospholipid
IT1212137B (it) * 1987-04-08 1989-11-08 Rosanna Lodi Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
US5001117A (en) * 1989-03-07 1991-03-19 Pharmacaps, Inc. Use of lecithin to restore olfaction and taste
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
IT1255476B (it) * 1992-07-30 1995-11-02 Glicerofosfoderivati farmacologicamente attivi
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
IL118180A (en) * 1996-05-08 2000-12-06 Modus Biolog Membranes Ltd Pharmaceutical compositions comprising a phosphatidic acid (PA) enriched natural phospholipid preparation and the production of such preparation
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
IL121322A (en) * 1997-07-16 2002-07-25 Modus Biolog Membranes Ltd Modular pharmacological preparation of the immune system based on fats and its preparation
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
AU1029500A (en) * 1998-08-29 2000-03-21 Miklos Ghyczy Pharmaceutical and/or diet product
US6592910B1 (en) * 1999-04-20 2003-07-15 Board Of Trustees, Southern Illinois University Methods of treating clinical diseases with isoflavones
CA2380640A1 (en) * 1999-08-18 2001-02-22 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent
US20060063738A1 (en) * 2000-02-28 2006-03-23 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6683066B2 (en) 2001-09-24 2004-01-27 Yanming Wang Composition and treatment method for brain and spinal cord injuries
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
IL158552A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Lipids containing omega-3 fatty acids
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
US8052992B2 (en) 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
US7691417B2 (en) 2004-09-02 2010-04-06 Clemson University Research Foundation Tumor and mutation suppressing plant extract

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3772360A (en) * 1969-07-01 1973-11-13 Smithkline Corp Adamantyl substituted glycerophosphoryl(and phosphonyl)ethanolamines

Also Published As

Publication number Publication date
DE2907778C2 (cg-RX-API-DMAC7.html) 1990-09-06
US4263286A (en) 1981-04-21
NL7901601A (nl) 1979-08-30
JPS54117034A (en) 1979-09-11
DE2907778A1 (de) 1979-08-30

Similar Documents

Publication Publication Date Title
US4263286A (en) Therapeutic agent for consciousness disorder and perception and movement disorder
Vickers Gammahydroxybutyric acid
US20120329765A1 (en) Medicinal targeted local lipolysis
US6335021B1 (en) Composition for controlling mood disorders in healthy individuals
EP1885379B1 (en) Compounds and methods for treating seizure and paroxysmal disorders
EP1684722B1 (de) Medikamentöse gezielte lokale lipolyse
CN101610775B (zh) 含有环状磷脂酸衍生物的镇痛剂
US20190247355A1 (en) Prophylaxis and mitigation of migraine headaches using medium chain triglycerides, ketone ester, and other ketonic sources
JPH0344324A (ja) 性機能賦活剤
GB2045612A (en) Pharmaceutical compositions containing phosphatidic acids for the treatment of disorders of consciousness perception and movement
DE3650735T2 (de) Verwendung von Cholin oder Cholin freisetzenden Verbindungen zur Verringerung der Empfingdung von Ermüdung
JPH0142925B2 (cg-RX-API-DMAC7.html)
DE602005005454T2 (de) Behandlung von Einschlusskörper-Myositis
JP2022136242A (ja) エピナスチン又はその塩を含有する花粉破裂抑制剤
US8975298B2 (en) Therapeutic agent for pain
DE3234061A1 (de) Antiepileptika
Kelly et al. Treatment of progressive myoclonic epilepsy with mephenesin
Altschul Effects of dithiobiuret on the central nervous system.
Doty et al. 0284 Transcranial Direct Current Brain Stimulation Is Well Tolerated During Sleep Deprivation
DE2102831C3 (de) Pyridoxin-Ester, deren Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
Onuaguluchi Drug therapy in the crises of postencephalitic parkinsonism
CN118286197A (zh) 瑞替加滨与(+)-冰片的组合物在抗癫痫中的应用
Edelist et al. Comparison of etidocaine and lidocaine for obstetrical analgesia
JPH1025252A (ja) 補体依存性疾患治療剤
Sinigar A Case of Ophthalmoplegia Externa and Paralysis of Both Facial Nerves, and a Case of Paralysis of Both Facial Nerves with some Affection of the Limbs, from Peripheral Neuritis; Recovery